Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Mallinckrodt completes Stratatech acquisition

Sep. 1, 2016

Galectin's GR-MD-02 doesn't perform well enough in phase IIa trial

Aug. 26, 2016

Final phase IIa trial results for the first topical gel formulation of minocycline, BPX-01

Aug. 23, 2016

Mayne Pharma acquires dermatology-related assets from GlaxoSmithKline

Aug. 19, 2016

Aclaris Therapeutics reports data from WART-201 phase II trial

Aug. 19, 2016

AstraZeneca and Leo Pharma complete tralokinumab licensing agreement

Aug. 16, 2016

Mallinckrodt to acquire Stratatech Corporation

Aug. 12, 2016

Japan Tobacco, Torii and Menlo enter serlopitant license agreement

Aug. 12, 2016

Abeona Therapeutics enters collaboration for research on epidermolysis bullosa

Aug. 11, 2016

Aldeyra Therapeutics reports positive results for NS-2 trial

Aug. 10, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...